tetrahydrocortisol has been researched along with Endometrial Neoplasms in 2 studies
Endometrial Neoplasms: Tumors or cancer of ENDOMETRIUM, the mucous lining of the UTERUS. These neoplasms can be benign or malignant. Their classification and grading are based on the various cell types and the percent of undifferentiated cells.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujimoto, J | 2 |
| Hori, M | 1 |
| Ichigo, S | 2 |
| Tamaya, T | 2 |
| Sakaguchi, H | 1 |
| Hirose, R | 1 |
2 other studies available for tetrahydrocortisol and Endometrial Neoplasms
| Article | Year |
|---|---|
Antiestrogenic compounds inhibit estrogen-induced expression of fibroblast growth factor family (FGF-1, 2, and 4) mRNA in well-differentiated endometrial cancer cells.
Topics: Adenocarcinoma; Cell Differentiation; Danazol; Endometrial Neoplasms; Estradiol; Estrogen Antagonist | 1997 |
Progestins suppress estrogen-induced expression of vascular endothelial growth factor (VEGF) subtypes in uterine endometrial cancer cells.
Topics: 17-alpha-Hydroxyprogesterone; Blotting, Southern; Blotting, Western; Dose-Response Relationship, Dru | 1999 |